Open-label Adjunctive Zonisamide for Bipolar Disorder
NCT00047567 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2015-12-14
Summary
To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.
Conditions
- Bipolar Disorders
Interventions
- DRUG
-
zonisamide
Sponsors & Collaborators
-
Elan Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
- Completion
- 2002-07-31
More Related Trials
-
Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
NCT00723450 ·Status: COMPLETED ·Phase: PHASE3
-
Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
NCT00036582 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
NCT00150605 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder
NCT00150553 ·Status: COMPLETED ·Phase: PHASE3
-
Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression
NCT00475137 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
NCT00265330 ·Status: COMPLETED ·Phase: PHASE3
-
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
NCT00221429 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
NCT00650611 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
NCT01674010 ·Status: TERMINATED ·Phase: PHASE2
-
Lithium for the Treatment of Pediatric Mania
NCT00442039 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
NCT01117220 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
NCT05169710 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder
NCT04987658 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.
NCT01166425 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Aripiprazole in Children and Adolescents With Bipolar I Disorder
NCT00110461 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania
NCT01495156 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)
NCT01244815 ·Status: COMPLETED ·Phase: PHASE3
-
Lurasidone Pediatric Bipolar Study
NCT02046369 ·Status: COMPLETED ·Phase: PHASE3
-
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
NCT00176228 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
NCT02456454 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Treatment of Bipolar II Depression
NCT00074776 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
NCT00360126 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
NCT00195767 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
NCT01504659 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
NCT00181922 ·Status: COMPLETED ·Phase: PHASE4